Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Director/PDMR Shareholding

5 Oct 2016 16:32

RNS Number : 8106L
Cello Group plc
05 October 2016
 

4 October 2016

Cello Group plc

("Cello" or the "Company")

 

Director/PDMR Shareholding

 

The Company has received notification that on 4 October 2016, Jane Shirley, a director of Cello Health, bought 2,331 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at a purchase price of 107.4 pence per Ordinary Share.

 

Following the purchase, Jane Shirley holds 78,000 Ordinary Shares representing 0.1% of the current issued share capital of the Company.

 

 

Contacts:

 

 Cello Group 020 7812 8460

 Mark Scott, Chief Executive

 Mark Bentley, Finance Director

 

 Cenkos Securities 0207 397 8900

 Bobbie Hilliam

 Harry Pardoe

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Jane Shirley

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director of Cello Signal

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Cello Group plc

b)

 

LEI

 

 

N/a

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of 10p each

 

 

 

 

b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

107.4p

 

2,331

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

2,331

 

 

107.4p

e)

 

Date of the transaction

 

 

4 October 2016

f)

 

Place of the transaction

 

 

London Stock Exchange

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUVOVRNUARRAA
Date   Source Headline
11th Jan 20064:35 pmRNSNotifiable Interest
11th Jan 20067:00 amRNSPre Close Trading Statement
3rd Jan 20063:44 pmRNSHolding(s) in Company
19th Dec 20057:17 amRNSAcquisition
16th Dec 20051:57 pmRNSAdditional Listing
25th Nov 200512:53 pmRNSAcquisition
20th Oct 20058:00 amRNSInvestor Presentation
14th Oct 20058:00 amRNSChange of Adviser
3rd Oct 20057:00 amRNSOMP Services
27th Sep 20057:02 amRNSInterim Results
2nd Sep 200511:41 amRNSNotice of Results
1st Aug 20057:00 amRNSAcquisition
18th Jul 20057:00 amRNSAcquisition
14th Jul 20059:14 amRNSHolding(s) in Company
11th Jul 20057:00 amRNSPre Close Trading Statement
4th Jul 20055:44 pmRNSHolding(s) in Company
1st Jul 20057:00 amRNSAcquisition
7th Jun 20052:46 pmRNSDirector Share Option Award
6th Jun 20054:43 pmRNSAcquisition Agreement
23rd May 200512:30 pmRNSAGM Statement
4th May 20058:41 amRNSBoard Appointment
25th Apr 20057:00 amRNSBoard Appointment
14th Mar 20057:01 amRNSFinal Results
10th Mar 20054:18 pmRNSHolding(s) in Company
1st Feb 200512:00 pmRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.